NAD+
Cellular Energy + Longevity
Energy begins with cellular chemistry.
A central molecule in cellular energy metabolism—and a reminder that well-understood biology and proven wellness benefits are different questions.
Evidence reviewed October 2, 2026 · Educational overview
01 / THE COMPOUND
What is it?
Nicotinamide adenine dinucleotide is a coenzyme involved in cellular redox reactions. Its oxidized form, NAD+, participates in the chemistry through which cells process energy. Research also examines NAD metabolism in aging. [1,2]
02 / THE OPPORTUNITY TO LEARN
Why researchers are interested
Energy at the cellular level
Researchers measure NAD and related metabolites to understand how cells maintain this essential system. Changes in a blood biomarker do not necessarily mean someone feels more energetic. [1,2]
The healthy-aging question
Human studies of nicotinamide riboside (NR), a precursor used to make NAD+, have examined changes in NAD metabolism. NR and directly administered NAD+ are different interventions. [2]
Following the molecule
Direct NAD+ studies have explored metabolic fate and short-term tolerability. These are useful early questions, but they do not establish performance enhancement or longer life. [1,3]
03 / RESEARCH INTEREST
Follow the questions.
04 / THE BIOLOGY
How it works
- NAD+ / NADH redox pair
- Cellular energy reactions
- Metabolism under investigation
NAD+ accepts electrons and becomes NADH during metabolic reactions; the two forms participate in cellular energy transfer. Raising a circulating measurement does not demonstrate delivery to every tissue or an improvement in health. [1,2]
05 / PUBLISHED FINDINGS
What research has observed
Early human research
A 2019 pilot compared eight NAD+ recipients with three saline controls and tracked blood and urine metabolites over hours. It was not a trial of longevity, sustained energy, or disease treatment. [1]
Controlled human research — different molecule
A 2018 randomized crossover trial found that oral NR increased NAD metabolism in middle-aged and older adults. Those results cannot be assigned to an NAD+ vial. [2]
Observational human research
A 2026 retrospective pilot compared commercially administered NAD+ and NR with a focus on tolerability and short-term safety markers. Retrospective comparisons cannot establish clinical efficacy. [3]
06 / EVIDENCE SNAPSHOT
Different evidence. Different conclusions.
These descriptive labels summarize the selected evidence. They are not numerical quality scores or product ratings.
- Biological mechanism
- Established role in cellular metabolism
- Human research
- Small direct-NAD+ studies; precursor evidence is separate
- Therapeutic use
- No energy or longevity indication claimed
07 / OPEN QUESTIONS
What we still don’t know
Whether direct NAD+ meaningfully improves energy, physical performance, or healthy lifespan requires stronger outcome-focused trials. Formulation, tissue delivery, longer-term safety, and findings from different precursors should not be treated as interchangeable.
08 / GO TO THE SOURCE
Selected research
09 / TRACEABILITY
Testing & documentation
Published studies are not a Certificate of Analysis for our inventory.
No verified lot-specific reports have been supplied for this compound. Identity, assay, purity, laboratory, testing date, sterility, endotoxin, and expiration must be supported by the applicable record before a claim is shown.
10 / RESEARCH FORMATS
From the inventory
1,000 mg is listed in the inventory. Physical form, batch documentation, and stock are not yet verified. This listing is not a statement of availability.
Inventory references: NAD-1000
Membership does not change the evidence or imply that ordering is available. Research information is not medical advice or a protocol for human use.